Literature DB >> 10195392

Characterization of human skin-derived CD1a-positive lymph cells.

C U Brand1, R E Hunger, N Yawalkar, H A Gerber, T Schaffner, L R Braathen.   

Abstract

The phenotype and function of CD1a+ lymph cells is of considerable interest. By means of microsurgical lymph cannulation human lymph derived from normal skin was sampled. Cells were isolated and processed for immunocytochemistry, electron microscopy, flow cytometry and functional assays. The majority of the cells, (62%), were T cells. The other cells comprised CD1a+ cells (7%), monocytes/macrophages (8%), and B cells (1%); the remainder were erythrocytes or uncharacterized cells. The CD1a+ cells reacted with antibodies against protein S-100, HLA-DR, the Lag antigen, CD4, CD11a, CD11b, CD18, CD25, CD40, CD54, CD80 and CD86. Interestingly, a small prolow portion the of CD1a+ cells (about 5%) reacted with an antibody to CD14. The CD1a+ cells did not react with an antibody against human follicular dendritic cells nor were they CD19-, CD23-, E-cadherin- or factor XIIIa-positive. Both allogenic and antigen-specific T cell proliferation stimulated by antigen-presenting lymph cells were strongly inhibited by adding anti-CD80 and anti-CD86 antibodies. By electron microscopy Birbeck granules were detected in only 22% of the CD1a+ lymph cells and these cells exhibited an extensive ruffling of the surface. These findings demonstrate that CD1a+ lymph cells, which do not express the dermal dendritic cell marker factor XIIIa, resemble dendritic cells formerly designated as 'veiled' as well as lymphoid dendritic cells, suggesting that after migration to the regional lymphoid organs, Langerhans cells form a more differentiated population of dendritic cells specialized in sensitizing T lymphocytes. Our results add further support to the view that resident Langerhans cells may be precursors of lymphoid dendritic cells acquiring the final phenotype in the microenvironment of the lymph node.

Entities:  

Mesh:

Year:  1999        PMID: 10195392     DOI: 10.1007/s004030050385

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  7 in total

Review 1.  Factors and signals that govern the migration of dendritic cells via lymphatics: recent advances.

Authors:  Gwendalyn J Randolph; Guzman Sanchez-Schmitz; Veronique Angeli
Journal:  Springer Semin Immunopathol       Date:  2005-01

2.  Distinctive localization of antigen-presenting cells in human lymph nodes.

Authors:  Catherine E Angel; Chun-Jen J Chen; Oliver C Horlacher; Sintia Winkler; Thomas John; Judy Browning; Duncan MacGregor; Jonathan Cebon; P Rod Dunbar
Journal:  Blood       Date:  2008-11-05       Impact factor: 22.113

3.  Matched skin and sentinel lymph node samples of melanoma patients reveal exclusive migration of mature dendritic cells.

Authors:  Barbara G Molenkamp; Ronald J C L M Vuylsteke; Paul A M van Leeuwen; Sybren Meijer; Wim Vos; Pepijn G J T B Wijnands; Rik J Scheper; Tanja D de Gruijl
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

4.  TNF-alpha-treated DC exacerbates disease in a murine tumor metastasis model.

Authors:  Nasreen Vohra; Monique Verhaegen; Lisa Martin; Amy Mackay; Shari Pilon-Thomas
Journal:  Cancer Immunol Immunother       Date:  2010-05       Impact factor: 6.968

5.  A three-dimensional atlas of human dermal leukocytes, lymphatics, and blood vessels.

Authors:  Xiao-Nong Wang; Naomi McGovern; Merry Gunawan; Connor Richardson; Martin Windebank; Tee-Wei Siah; Hwee-Ying Lim; Katja Fink; Jackson L Yao Li; Lai G Ng; Florent Ginhoux; Veronique Angeli; Matthew Collin; Muzlifah Haniffa
Journal:  J Invest Dermatol       Date:  2013-11-11       Impact factor: 8.551

6.  Dendritic Cells and T Cells Interact Within Murine Afferent Lymphatic Capillaries.

Authors:  Morgan Campbell Hunter; Alvaro Teijeira; Riccardo Montecchi; Erica Russo; Peter Runge; Friedemann Kiefer; Cornelia Halin
Journal:  Front Immunol       Date:  2019-03-22       Impact factor: 7.561

7.  Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer.

Authors:  Michal Radomski; Herbert J Zeh; Howard D Edington; James F Pingpank; Lisa H Butterfield; Theresa L Whiteside; Eva Wieckowski; David L Bartlett; Pawel Kalinski
Journal:  J Immunother Cancer       Date:  2016-04-19       Impact factor: 13.751

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.